2-[1-(2-phenyl-1,3-dioxan-5-yl)cyclohexyl]ethanol | 518285-34-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二恶烷
• 英文名称: 2-[1-(2-phenyl-1,3-dioxan-5-yl)cyclohexyl]ethanol
• CAS: 518285-34-2
• 化学式: C₁₈H₂₆O₃
• 分子量: 290.403
• InChiKey: OEZKRFQVSQLPGN-UHFFFAOYSA-N

物化性质

• 沸点：
  426.3±30.0 °C(Predicted)
• 密度：
  1.090±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-[1-(2-hydroxyethyl)cyclohexyl]propane-1,3-diol 、 苯甲醛二乙缩醛 在 4-甲基苯磺酸吡啶 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 16.0h， 生成 2-[1-(2-phenyl-1,3-dioxan-5-yl)cyclohexyl]ethanol
  参考文献：
  名称：

  NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME

  摘要：

  公开号：

  EP1443046B1

文献信息

• Novel 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
  申请人：Fukutomi Ryuuta

  公开号：US20050085508A1

  公开（公告）日：2005-04-21

  There are provided novel 4-(2-furoyl)aminopiperidines represented by the general formula (I), their synthetic intermediates, processes for their preparation and medicaments containing them. In the above formula, X is CH or N, and Y is a group of the following general formula (II), formula (II-a) or formula (III): wherein a, b and c are each an integer of 0-6; Z is CH 2 or NH; W is O or S; T is O or N—R 15 wherein R 15 is H, a C1-C6 alkyl group, a benzyl group or a phenethyl group; and R 1 is H, a C1-C6 alkoxycarbonyl group, a benzyloxycarbonyl group, or the like. The 4-(2-furoyl)aminopiperidine derivatives according to this invention possess opioid μ antagonistic activity and are useful for the treatment or prevention of side effects which are caused by μ receptors agonist and which are selected from constipation, nausea/emesis or itch, or for the treatment or prevention of idiopathic constipation, postoperative ileus, paralytic ileus, irritable bowel syndrome or chronic pruritus.

  提供了一种新的4-(2-呋喃酰基)氨基哌啶化合物，其通式表示为(I)，以及它们的合成中间体、制备过程和含有它们的药物。 在上述式中，X为CH或N，Y为以下通式(II)、式(II-a)或式(III)的基团： 其中a、b和c均为0-6的整数；Z为CH2或NH；W为O或S；T为O或N—R15，其中R15为H、C1-C6烷基、苄基或苯乙基；R1为H、C1-C6烷氧羰基、苄氧羰基或类似基团。本发明所述的4-(2-呋喃酰基)氨基哌啶衍生物具有阿片μ受体拮抗活性，可用于治疗或预防由μ受体激动剂引起的副作用，包括便秘、恶心/呕吐或瘙痒，或用于治疗或预防特发性便秘、术后肠梗阻、麻痹性肠梗阻、肠易激综合征或慢性瘙痒。
• Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same
  申请人：Fukutomi Ryuuta

  公开号：US20080194826A1

  公开（公告）日：2008-08-14

  A compound represented the general formula (V): wherein X is CH or N; and Y a is a group of the general formula selected from:

  一个化合物的一般式表示为(V)：其中X是CH或N; 而Y是从一般式中选择的一个基团：
• 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
  申请人：Kyorin Pharmaceutical Co., Ltd.

  公开号：US07375115B2

  公开（公告）日：2008-05-20

  There are provided novel 4(2-furoyl)aminopiperidines represented by the general formula (I), their synthetic intermediates, processes for their preparation and medicaments containing them. In the above formula, X is OH or N, and Y is a group of the following general formula (II), formula (II-a) or formula (III): wherein a, b and c are each an integer of 0-6; Z is CH2 or NH; W is O or S; T is O or N—R15 wherein R15 is H, a C1-C6 alkyl group, a benzyl group or a phenethyl group; and R1 is H, a C1-C6 alkoxycarbonyl group, a benzyloxy-carbonyl group, or the like. The 4-(2-furoyl)aminopiperidine derivatives according to this invention possess opioid μ antagonistic activity and are useful for the treatment or prevention of side effects which are caused by μ receptors agonist and which are selected from constipation, nausea/emesis or itch, or for the treatment or prevention of idiopathic constipation, postoperative ileus, paralytic ileus, irritable bowel syndrome or chronic pruritus.

  提供了一种新型的4（2-呋喃基）氨基哌啶，其通式为（I），以及它们的合成中间体、制备方法和含有它们的药物。在上述公式中，X为OH或N，而Y为以下通式（II）、公式（II-a）或公式（III）的一种：其中a、b和c均为0-6的整数；Z为CH2或NH；W为O或S；T为O或N-R15，其中R15为H、C1-C6烷基、苄基或苯乙基；而R1为H、C1-C6烷氧羰基、苄氧羰基或类似物。根据本发明的4-(2-呋喃基)氨基哌啶衍生物具有阿片μ拮抗活性，并可用于治疗或预防由μ受体激动剂引起的副作用，包括便秘、恶心/呕吐或瘙痒，或用于治疗或预防特发性便秘、术后肠梗阻、麻痹性肠梗阻、肠易激综合征或慢性瘙痒。
• US7375115B2
  申请人：——

  公开号：US7375115B2

  公开（公告）日：2008-05-20
• NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME
  申请人：Kyorin Pharmaceutical Co., Ltd.

  公开号：EP1443046B1

  公开（公告）日：2008-12-17